QQ客服 官方微博 反馈留言

	Histopathological and proteomic analyses identify integrin-beta 1 as a potential mediator of phlebosclerosis in uremic patients
	Zhou, Chunyu; Li, Changbin; Wang, Qiang; Wu, Mingyu; Mohan, Chandra; Hu, Dayong; Peng, Ai
刊名	CLINICAL AND EXPERIMENTAL NEPHROLOGY
	2019
卷号	23期号:9页码:1100-1108
关键词	Uremia Phlebosclerosis Proteomics Integrin-beta 1
DOI	10.1007/s10157-019-01755-0
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4556338
专题	山东大学
作者单位	Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Ctr Nephrol & Metabol,
推荐引用方式 GB/T 7714	Zhou, Chunyu,Li, Changbin,Wang, Qiang,et al. Histopathological and proteomic analyses identify integrin-beta 1 as a potential mediator of phlebosclerosis in uremic patients[J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY,2019,23(9):1100-1108.
APA	Zhou, Chunyu.,Li, Changbin.,Wang, Qiang.,Wu, Mingyu.,Mohan, Chandra.,...&Peng, Ai.(2019).Histopathological and proteomic analyses identify integrin-beta 1 as a potential mediator of phlebosclerosis in uremic patients.CLINICAL AND EXPERIMENTAL NEPHROLOGY,23(9),1100-1108.
MLA	Zhou, Chunyu,et al."Histopathological and proteomic analyses identify integrin-beta 1 as a potential mediator of phlebosclerosis in uremic patients".CLINICAL AND EXPERIMENTAL NEPHROLOGY 23.9(2019):1100-1108.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。